Gamelin Erick bought ACRV
May 18, 2026 · Form 4 insider transaction
Gamelin Erick bought 38,584 shares of Acrivon Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
38,584
Price
$0.00
Total value
N/A
InsiderGamelin Erick
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 18, 2026
Filing dateMay 20, 2026
Shares owned after52,992
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Of these RSUs, 16.67% of the RSUs shall vest on November 18, 2026, and the remaining RSUs shall vest in 10 substantially equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.